Daiichi Sankyo will retool its commercial organization, and Ken Keller will be at the center of it all as chief commercialization officer.
→ Daiichi Sankyo will retool its commercial organization, and Ken Keller will be at the center of it all as chief commercialization officer. On April …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Lead New Commercialization Unit to Accelerate Growth of…
CDMO Lonza is strengthening its market leadership with a newly created role that puts seasoned exec Samanta Cimitan, Ph.D., at…
Il gruppo farmaceutico danese alle prese con una crisi strategica, tra sfide di mercato e cambiamento culturale nel settore…
In its second-quarter results, Novo disclosed a partial miss in a Phase 3 diabetes trial of CagriSema. And it ended work on an…
Mike Doustdar setzt alles daran, den Konzern im Rennen gegen US-Rivalen Eli Lilly wieder nach vorn zu bringen. Ein Mann mit einer…
Novo Nordisk has made Omnicom the agency of record for U.S. media buying, ending the drugmaker’s six-year partnership with WPP’s…
